At the molecular level, M2-TAMs induced by iCCA cells promote tumor growth and invasion through the EMT signaling pathway involving IL-10 and STAT3, suggesting a potential new target for iCCA therapy (78). The gene discussed is IL10; the disease is neoplasm.